DGX vs. JNJ
Compare and contrast key facts about Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DGX or JNJ.
Correlation
The correlation between DGX and JNJ is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DGX vs. JNJ - Performance Comparison
Key characteristics
DGX:
0.77
JNJ:
-0.35
DGX:
1.35
JNJ:
-0.41
DGX:
1.15
JNJ:
0.95
DGX:
0.62
JNJ:
-0.31
DGX:
4.06
JNJ:
-0.79
DGX:
3.80%
JNJ:
6.88%
DGX:
19.98%
JNJ:
15.48%
DGX:
-49.46%
JNJ:
-52.60%
DGX:
-7.29%
JNJ:
-14.32%
Fundamentals
DGX:
$16.93B
JNJ:
$353.99B
DGX:
$7.42
JNJ:
$6.04
DGX:
20.38
JNJ:
24.34
DGX:
1.77
JNJ:
0.86
DGX:
$7.25B
JNJ:
$66.30B
DGX:
$2.34B
JNJ:
$45.96B
DGX:
$1.39B
JNJ:
$22.61B
Returns By Period
In the year-to-date period, DGX achieves a 0.72% return, which is significantly lower than JNJ's 1.67% return. Over the past 10 years, DGX has outperformed JNJ with an annualized return of 10.38%, while JNJ has yielded a comparatively lower 6.72% annualized return.
DGX
0.72%
0.28%
4.58%
16.46%
9.48%
10.38%
JNJ
1.67%
1.58%
-3.46%
-5.91%
2.52%
6.72%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DGX vs. JNJ — Risk-Adjusted Performance Rank
DGX
JNJ
DGX vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DGX vs. JNJ - Dividend Comparison
DGX's dividend yield for the trailing twelve months is around 1.98%, less than JNJ's 3.34% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.98% | 1.96% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% |
JNJ Johnson & Johnson | 3.34% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
DGX vs. JNJ - Drawdown Comparison
The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for DGX and JNJ. For additional features, visit the drawdowns tool.
Volatility
DGX vs. JNJ - Volatility Comparison
The current volatility for Quest Diagnostics Incorporated (DGX) is 4.93%, while Johnson & Johnson (JNJ) has a volatility of 5.21%. This indicates that DGX experiences smaller price fluctuations and is considered to be less risky than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DGX vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities